Pacific Point Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.86M Sell
8,000
-2,000
-20% -$531K 1.76% 10
2026
Q1
$1.1M Hold
10,000
0.58% 62
2025
Q4
$1.66M Buy
10,000
+1,500
+18% +$251K 0.89% 25
2025
Q3
$1.66M Sell
8,500
-1,500
-15% -$247K 0.97% 25
2025
Q2
$904K Buy
10,000
+3,000
+43% +$237K 0.49% 55
2025
Q1
$418K Buy
7,000
+3,000
+75% +$278K 0.23% 86
2024
Q4
$530K Buy
+4,000
New +$375K 0.32% 74

Other funds holding ALAB

Pacific Point Advisors's ALAB Position: Q2 2026 in Review

Pacific Point Advisors reduced its Astera Labs (ALAB) stake by 20% in Q2 2026, selling an estimated $531K and leaving 8,000 shares worth $3.86M. The position accounts for 1.76% of the portfolio, ranked #10.

Pacific Point Advisors first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Pacific Point Advisors held 8,000 shares of Astera Labs worth $3.86M as of Q2 2026.
  • Pacific Point Advisors sold 2,000 Astera Labs shares in Q2 2026, an estimated $531K.
  • Astera Labs made up 1.76% of Pacific Point Advisors's portfolio in Q2 2026, its #10 holding.
  • Pacific Point Advisors first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Pacific Point Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.